Neuberger Berman Group
RARE icon

Neuberger Berman Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Neuberger Berman Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,608
Closed -$236K – 2037
2024
Q4 		$236K Sell
5,608
-6
-0.1% -$298 ﹤0.01% 1744
2024
Q3 		$312K Buy
+5,614
New +$286K ﹤0.01% 1672
2024
Q2 		– Sell
-104,939
Closed -$4.9M – 1957
2024
Q1 		$4.9M Sell
104,939
-34,553
-25% -$1.63M ﹤0.01% 931
2023
Q4 		$6.67M Buy
139,492
+6,506
+5% +$252K ﹤0.01% 1003
2023
Q3 		$4.74M Buy
132,986
+30,341
+30% +$1.2M ﹤0.01% 890
2023
Q2 		$4.74M Buy
102,645
+33,969
+49% +$1.58M ﹤0.01% 902
2023
Q1 		$2.75M Buy
68,676
+28,890
+73% +$1.24M ﹤0.01% 1003
2022
Q4 		$1.84M Buy
+39,786
New +$1.56M ﹤0.01% 1087
2021
Q2 		– Sell
-18,585
Closed -$2.12M – 1826
2021
Q1 		$2.12M Sell
18,585
-6,042
-25% -$823K ﹤0.01% 1138
2020
Q4 		$3.41M Sell
24,627
-2,373
-9% -$282K ﹤0.01% 1005
2020
Q3 		$2.22M Buy
27,000
+7,000
+35% +$580K ﹤0.01% 1045
2020
Q2 		$1.56M Sell
20,000
-2,000
-9% -$132K ﹤0.01% 1060
2020
Q1 		$977K Buy
+22,000
New +$1.14M ﹤0.01% 1101

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Neuberger Berman Group's RARE Position: Q1 2025 in Review

Neuberger Berman Group sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2025, closing a stake of 5,608 shares — an estimated $236K sold.

Neuberger Berman Group first reported a position in RARE in Q1 2020 and held it in 13 quarters. The position peaked at $6.67M in Q4 2023. 300 funds tracked by Wall St. Rank hold RARE as of Q1 2025.

  • Neuberger Berman Group reported no remaining Ultragenyx Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 5,608 Ultragenyx Pharmaceutical shares in Q1 2025, an estimated $236K.
  • Neuberger Berman Group first reported a position in Ultragenyx Pharmaceutical in Q1 2020 and held it in 13 quarters.
  • Neuberger Berman Group's Ultragenyx Pharmaceutical position peaked at $6.67M in Q4 2023.
  • 300 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2025.

Based on Neuberger Berman Group's 13F filing for Q1 2025, filed 13 May 2025.